By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mitsubishi Tanabe Pharma Corporation 

3-2-10, Dosho-machi, Chuo-ku

Osaka    541-8505  Japan
Phone: n/a Fax: n/a



Company News
NeuroDerm (NDRM) Announces Extraordinary General Meeting Of Shareholders To Approve Acquisition By Mitsubishi Tanabe 8/2/2017 11:10:26 AM
Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for This Parkinson's Biotech 7/24/2017 6:09:44 AM
Clinigen Signs Exclusive Supply Agreements In Global Access With Mitsubishi Tanabe, Shionogi And Romark Laboratories, L.C. 6/21/2017 7:32:19 AM
Mitsubishi Tanabe Wins FDA Approval for Radicava, the First New ALS Drug in 22 Years 5/8/2017 5:41:52 AM
Biogen (BIIB) Quietly Terminates Deal With Mitsubishi Tanabe 1/27/2017 6:35:30 AM
Mitsubishi Tanabe Release: 12-month Edaravone Clinical Study Data In ALS Presented At The 27th International Symposium On ALS/MND 12/9/2016 6:59:45 AM
FDA Accepts Mitsubishi Tanabe's NDA Filing For Edaravone To Treat ALS 8/30/2016 7:57:44 AM
Mitsubishi Tanabe Joins Certara Corporation’s Simcyp Consortium 7/20/2016 11:00:59 AM
Mitsubishi Tanabe Submits New Drug Application For Edaravone To Treat ALS In The United States 6/20/2016 7:06:51 AM
GHIT Fund Welcomes Ten New Partnerships With FUJIFILM, Otsuka, GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Kyowa Hakko Kirin, Merck & Co. (MRK), Mitsubishi Tanabe, Nipro Corporation, Sumitomo Dainippon Pharma Co., Ltd. And Salesforce.Com 6/6/2016 12:09:47 PM